Literature DB >> 19679113

Targeting ADAM10 to lipid rafts in neuroblastoma SH-SY5Y cells impairs amyloidogenic processing of the amyloid precursor protein.

Benjamin Harris1, Isabel Pereira, Edward Parkin.   

Abstract

ADAM10 (a disintegrin and metalloproteinase 10) is the principal alpha-secretase responsible for the non-amyloidogenic processing of the Alzheimer's disease (AD)-associated amyloid precursor protein (APP). A reciprocal relationship exists between non-amyloidogenic and amyloidogenic APP processing such that impaired ADAM10-mediated proteolysis of the protein serves to enhance amyloidogenic processing (by beta- and gamma-secretases) thereby elevating levels of the amyloid beta (A beta)-peptides responsible for the neuronal death observed in the AD-afflicted brain. It has previously been demonstrated that the amyloidogenic processing of APP occurs within specialized regions of the cell membrane known as lipid rafts. Conversely, ADAM10-mediated non-amyloidogenic processing is thought to occur in the non-raft region of the membrane with the majority of ADAM10 being excluded from rafts. In the current study, we hypothesized that the exclusion of ADAM10 from rafts may leave the APP substrate particularly susceptible to alternative beta-secretase cleavage within these microdomains. In order to test this hypothesis, we targeted ADAM10 to rafts by replacing its transmembrane and cytosolic regions with a glycosylphosphatidylinositol (GPI) anchor and examined the associated effects on APP proteolysis. We found that whereas wild-type ADAM10 was exclusively present in the non-raft region of the membrane where it enhanced non-amyloidogenic APP proteolysis, GPI-anchored ADAM10 was effectively targeted to rafts where it competed with beta-secretase thereby reducing amyloidogenic APP processing. These results indicate that it is the exclusion of ADAM10 from rafts rather than simply the raft localization of beta- and gamma-secretases that underlies A beta-peptide generation within these cellular structures.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19679113     DOI: 10.1016/j.brainres.2009.07.105

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  25 in total

Review 1.  Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis.

Authors:  Norman J Haughey; Veera V R Bandaru; Mihyun Bae; Mark P Mattson
Journal:  Biochim Biophys Acta       Date:  2010-05-07

2.  Overexpression of sigma-1 receptor inhibits ADAM10 and ADAM17 mediated shedding in vitro.

Authors:  Juan Li; Bin Liu; Xiaofei Gao; Zhixing Ma; Tianyi CaoSong; Yan-ai Mei; Yufang Zheng
Journal:  Protein Cell       Date:  2012-02-09       Impact factor: 14.870

Review 3.  Regulation of α-secretase ADAM10 expression and activity.

Authors:  Kristina Endres; Falk Fahrenholz
Journal:  Exp Brain Res       Date:  2011-10-04       Impact factor: 1.972

4.  Low cholesterol triggers membrane microdomain-dependent CD44 shedding and suppresses tumor cell migration.

Authors:  Toshiyuki Murai; Yuusuke Maruyama; Kazuhiro Mio; Hidetoshi Nishiyama; Mitsuo Suga; Chikara Sato
Journal:  J Biol Chem       Date:  2010-11-17       Impact factor: 5.157

5.  Reciprocal modulation between amyloid precursor protein and synaptic membrane cholesterol revealed by live cell imaging.

Authors:  Claire E DelBove; Claire E Strothman; Roman M Lazarenko; Hui Huang; Charles R Sanders; Qi Zhang
Journal:  Neurobiol Dis       Date:  2019-03-15       Impact factor: 5.996

6.  Activation of TRPML1 clears intraneuronal Aβ in preclinical models of HIV infection.

Authors:  Mihyun Bae; Neha Patel; Haoxing Xu; Mingwaoh Lee; Kumiko Tominaga-Yamanaka; Avindra Nath; Jonathan Geiger; Myriam Gorospe; Mark P Mattson; Norman J Haughey
Journal:  J Neurosci       Date:  2014-08-20       Impact factor: 6.167

Review 7.  Direct binding of cholesterol to the amyloid precursor protein: An important interaction in lipid-Alzheimer's disease relationships?

Authors:  Andrew J Beel; Masayoshi Sakakura; Paul J Barrett; Charles R Sanders
Journal:  Biochim Biophys Acta       Date:  2010-03-18

8.  Zinc metalloproteinases and amyloid Beta-Peptide metabolism: the positive side of proteolysis in Alzheimer's disease.

Authors:  Mallory Gough; Catherine Parr-Sturgess; Edward Parkin
Journal:  Biochem Res Int       Date:  2010-09-30

9.  EpCAM proteolysis: new fragments with distinct functions?

Authors:  Ulrike Schnell; Jeroen Kuipers; Ben N G Giepmans
Journal:  Biosci Rep       Date:  2013-03-19       Impact factor: 3.840

10.  A glycosphingolipid binding domain controls trafficking and activity of the mammalian notch ligand delta-like 1.

Authors:  Sara Farrah Heuss; Nadine Tarantino; Jacques Fantini; Delphine Ndiaye-Lobry; Julien Moretti; Alain Israël; Frédérique Logeat
Journal:  PLoS One       Date:  2013-09-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.